Vaxart (STU:NB11) Shares Outstanding (Basic Average): 0.0 Mil (As of Mar. 2026)


STU:NB11 Vaxart Inc STU:NB11
59 GF Score
Price €0.60
GF Value €9.39
! 3 Warning Signs
View Full Analysis

What is Vaxart Shares Outstanding (Basic Average)?

Vaxart STU:NB11 59 Shares Outstanding (Basic Average) is 0.0 Mil as of Mar. 2026. GuruFocus rates STU:NB11 with a GF Score™ of 59/100 and a GF Value™ of €9.39. The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Vaxart's average basic shares outstanding for the quarter that ended in Mar. 2026 was 0.0 Mil.


Vaxart  (STU:NB11) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Vaxart Shares Outstanding (Basic Average) Related Terms


Vaxart Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Vaxart's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxart Shares Outstanding (Basic Average) Chart

Vaxart Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.45 127.68 144.82 202.14 230.27

Vaxart Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 227.92 228.37 228.93 235.86 0.00
STU:NB11
59GF Score
Vaxart Inc STU:NB11
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxart Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 0.0 Mil mean?
Vaxart (STU:NB11) has a Shares Outstanding (Basic Average) of 0.0 Mil as of Mar. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Vaxart and its competitors.
Is Vaxart's Shares Outstanding (Basic Average) too high?
Vaxart's current Shares Outstanding (Basic Average) is 0.0 Mil. Overall, Vaxart has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's Shares Outstanding (Basic Average) compare to ANTX and CNTB?
Vaxart's Shares Outstanding (Basic Average) of 0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Biotechnology company?
A good Shares Outstanding (Basic Average) depends on the Biotechnology industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Vaxart and its competitors. Vaxart's current Shares Outstanding (Basic Average) is 0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (STU:NB11) has a current Shares Outstanding (Basic Average) of 0.0 Mil. The stock's GF Value™ is €9.39, compared to a current price of €0.60 — trading 93.6% below its estimated fair value. The current Shares Outstanding (Basic Average) is 0.0 Mil. Vaxart's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Vaxart (STU:NB11), the current Shares Outstanding (Basic Average) is 0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxart (STU:NB11) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxart stock appears to be undervalued. The current stock price of €0.60 is trading 93.6% below its estimated GF Value™ of €9.39.

Key valuation signals for STU:NB11:

  • Shares Outstanding (Basic Average): 0.0 Mil
  • GF Value™: €9.39 vs. price of €0.60 (93.6% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the STU:NB11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vaxart Business Description

Other Exchanges VXRT:USA
Address 170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically, all the business activity functions through the region of the United States.
59GF Score

Get the complete analysis for STU:NB11

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.60
Price
€9.39
GF Value